Vertex Pharmaceuticals Inc (VRTX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 571,464 US Dollar | 20 | 6 | 5 | 0 | 1 |
| #Shares | Short [%] | Short Ratio |
| 253.300.000 | 1,9 | 3,66 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Vertex Pharmaceuticals Inc
Mitarbeiter 6.400
Handelsplatz NASDAQ
Ticker Symbol VRTX
IPO Datum 1991-07-24
Adresse 50 Northern Avenue, Boston, MA, United States, 02210
Webseite https://www.vrtx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jeffrey Marc Leiden M.D., Ph.D. | Executive Chairman |
| 2 | Dr. Reshma Kewalramani FASN, M.D. | CEO, President & Director |
| 3 | Mr. Charles F. Wagner Jr. | Executive VP, COO & CFO |
| 4 | Mr. Amit K. Sachdev J.D. | Executive VP & Chief Patient and External Affairs Officer |
| 5 | Dr. Ourania Tatsis Ph.D. | Executive VP & Chief Product Affairs Officer |
| 6 | Dr. Carmen Bozic M.D. | Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer |
| 7 | Ms. Kristen C. Ambrose CPA | Senior VP & Chief Accounting Officer |
| 8 | Dr. Mark Bunnage D.Phil | Executive VP & Chief Scientific Officer |
| 9 | Ms. Susie Lisa C.F.A. | Senior Vice President of Investor Relations |
| 10 | Ms. Joy Liu J.D. | EVP, Chief Legal Officer & Corporate Secretary |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Capital World Investors | 10,30% | 13,82 Mrd. USD |
| 2 | BlackRock Inc | 9,51% | 12,76 Mrd. USD |
| 3 | Capital Research Global Investors | 7,69% | 10,32 Mrd. USD |
| 4 | Vanguard Capital Management, LLC | 6,54% | 8,78 Mrd. USD |
| 5 | State Street Corp | 4,68% | 6,28 Mrd. USD |
| 6 | Amvescap Plc. | 3,17% | 4,26 Mrd. USD |
| 7 | JPMorgan Chase & Co | 2,57% | 3,45 Mrd. USD |
| 8 | Geode Capital Management, LLC | 2,37% | 3,19 Mrd. USD |
| 9 | Vanguard Portfolio Management, LLC | 1,92% | 2,58 Mrd. USD |
| 10 | Capital Research & Mgmt Co - Division 3 | 1,85% | 2,49 Mrd. USD |
| 11 | Loomis, Sayles & Company LP | 1,55% | 2,08 Mrd. USD |
| 12 | Franklin Templeton Inc | 1,32% | 1,77 Mrd. USD |
| 13 | Wellington Management Company LLP | 1,28% | 1,72 Mrd. USD |
| 14 | Morgan Stanley - Brokerage Accounts | 1,28% | 1,72 Mrd. USD |
| 15 | UBS Asset Mgmt Americas Inc | 1,22% | 1,63 Mrd. USD |
| 16 | Bank of America Corp | 1,20% | 1,61 Mrd. USD |
| 17 | AllianceBernstein L.P. | 1,19% | 1,60 Mrd. USD |
| 18 | Jennison Associates LLC | 1,18% | 1,59 Mrd. USD |
| 19 | NORGES BANK | 1,17% | 1,57 Mrd. USD |
| 20 | Ameriprise Financial Inc | 1,03% | 1,38 Mrd. USD |